TY - JOUR
T1 - Prevalence and correlates of increased lung/heart ratio of thallium-201 during dipyridamole stress imaging for suspected coronary artery disease
AU - Villanueva, Flordeliza S.
AU - Kaul, Sanjiv
AU - Smith, William H.
AU - Watson, Denny D.
AU - Varma, Shailendra K.
AU - Beller, George A.
PY - 1990/12/1
Y1 - 1990/12/1
N2 - There is little information concerning the prevalence and clinical correlates of increased pulmonary thallium-201 uptake during dipyridamole thallium-201 stress imaging. Accordingly, the clinical characteristics and quantitative thallium-201 findings were correlated with quantitative lung/heart thallium-201 ratio in 87 patients undergoing dipyridamole thallium-201 stress testing. Nineteen patients (22%) had an elevated ratio (>0.51). These patients were more likely to have had an infarction, to be taking β blockers, and have a lower rate-pressure product after dipyridamole administration than those with a normal ratio (p < 0.03). An elevated ratio was associated with a greater likelihood of initial, redistribution and persistent defects, as well as left ventricular cavity dilatation on thallium-201 imaging (p < 0.05). In addition, the number of myocardial segments demonstrating initial, redistribution and persistent defects was also greater in patients with increased ratios (p < 0.03). Multivariate analysis demonstrated that the presence of redistribution and left ventricular cavity dilatation were the most significant correlates of lung/heart thallium-201 ratio. It is concluded that the prevalence of increased lung/heart thallium-201 ratio with dipyridamole thallium-201 stress imaging is similar to that seen with exercise stress imaging. As with exercise thallium-201 imaging, increased pulmonary thallium-201 uptake may be a marker of functionally more significant coronary artery disease.
AB - There is little information concerning the prevalence and clinical correlates of increased pulmonary thallium-201 uptake during dipyridamole thallium-201 stress imaging. Accordingly, the clinical characteristics and quantitative thallium-201 findings were correlated with quantitative lung/heart thallium-201 ratio in 87 patients undergoing dipyridamole thallium-201 stress testing. Nineteen patients (22%) had an elevated ratio (>0.51). These patients were more likely to have had an infarction, to be taking β blockers, and have a lower rate-pressure product after dipyridamole administration than those with a normal ratio (p < 0.03). An elevated ratio was associated with a greater likelihood of initial, redistribution and persistent defects, as well as left ventricular cavity dilatation on thallium-201 imaging (p < 0.05). In addition, the number of myocardial segments demonstrating initial, redistribution and persistent defects was also greater in patients with increased ratios (p < 0.03). Multivariate analysis demonstrated that the presence of redistribution and left ventricular cavity dilatation were the most significant correlates of lung/heart thallium-201 ratio. It is concluded that the prevalence of increased lung/heart thallium-201 ratio with dipyridamole thallium-201 stress imaging is similar to that seen with exercise stress imaging. As with exercise thallium-201 imaging, increased pulmonary thallium-201 uptake may be a marker of functionally more significant coronary artery disease.
UR - http://www.scopus.com/inward/record.url?scp=0025201249&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0025201249&partnerID=8YFLogxK
U2 - 10.1016/0002-9149(90)91162-Y
DO - 10.1016/0002-9149(90)91162-Y
M3 - Article
C2 - 2244562
AN - SCOPUS:0025201249
SN - 0002-9149
VL - 66
SP - 1324
EP - 1328
JO - The American journal of cardiology
JF - The American journal of cardiology
IS - 19
ER -